Abingdon Health PLC
LSE:ABDX

Watchlist Manager
Abingdon Health PLC Logo
Abingdon Health PLC
LSE:ABDX
Watchlist
Price: 8.225 GBX 2.81% Market Closed
Market Cap: 15.9m GBX
Have any thoughts about
Abingdon Health PLC?
Write Note

Abingdon Health PLC
Depreciation & Amortization

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Abingdon Health PLC
Depreciation & Amortization Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
Abingdon Health PLC
LSE:ABDX
Depreciation & Amortization
ÂŁ759k
CAGR 3-Years
51%
CAGR 5-Years
17%
CAGR 10-Years
N/A
ConvaTec Group PLC
LSE:CTEC
Depreciation & Amortization
$214.8m
CAGR 3-Years
3%
CAGR 5-Years
2%
CAGR 10-Years
N/A
Tristel PLC
LSE:TSTL
Depreciation & Amortization
ÂŁ2.5m
CAGR 3-Years
-2%
CAGR 5-Years
10%
CAGR 10-Years
11%
Inspecs Group PLC
LSE:SPEC
Depreciation & Amortization
ÂŁ13m
CAGR 3-Years
49%
CAGR 5-Years
34%
CAGR 10-Years
N/A
Advanced Medical Solutions Group PLC
LSE:AMS
Depreciation & Amortization
ÂŁ11.3m
CAGR 3-Years
14%
CAGR 5-Years
18%
CAGR 10-Years
16%
Rua Life Sciences PLC
LSE:RUA
Depreciation & Amortization
ÂŁ364k
CAGR 3-Years
10%
CAGR 5-Years
11%
CAGR 10-Years
N/A
No Stocks Found

Abingdon Health PLC
Glance View

Market Cap
15.9m GBX
Industry
Health Care

Abingdon Health Plc develops, manufactures and commercializes immunoassay tests and reader systems. The company is headquartered in York, North Yorkshire and currently employs 151 full-time employees. The company went IPO on 2020-12-15. The firm operates through three segments: Contract Development, Contract Manufacturing and Product Sales. The Contract Development segment comprises development work for third parties and is recognized over time based on a proportion of completion. The Contract Manufacturing segment comprises contract development and manufacturing activities. The Product Sales segment comprises the sale of ABC-19, pocket diagnostic products, progressive rod cone degeneration (PCRD) tests and antibodies for research use. Its products also include Seralite, which includes Free Light Chain (FLC) Serum. The Company’s geographical market include the United Kingdom, the United States/Canada, rest of world (ROW).

ABDX Intrinsic Value
11.84 GBX
Undervaluation 31%
Intrinsic Value
Price

See Also

What is Abingdon Health PLC's Depreciation & Amortization?
Depreciation & Amortization
759k GBP

Based on the financial report for Jun 30, 2023, Abingdon Health PLC's Depreciation & Amortization amounts to 759k GBP.

What is Abingdon Health PLC's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
17%

Over the last year, the Depreciation & Amortization growth was -91%. The average annual Depreciation & Amortization growth rates for Abingdon Health PLC have been 51% over the past three years , 17% over the past five years .

Back to Top